Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Novel Drug Regimens for Lung Cancer
Recruiting1 awardPhase 2
Hackensack, New Jersey
This trial will compare the effectiveness of new regimens of drugs (either given together or as single agents) to the current standard of care in patients with advanced non-small cell lung cancer that has gotten worse despite treatment or come back after treatment. The trial will have two parts. The first part will be an optional part that is not randomized, where patients will be given the new drug to see if it is safe and to generate additional data. The second part will be a randomized, open-label part comparing the efficacy and safety of the new regimens of drugs to the standard of care.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.